Infectious diseases and immunity: Special reference to major histocompatibility complex

被引:0
|
作者
Singh, N [1 ]
Agrawal, S [1 ]
Rastogi, AK [1 ]
机构
[1] SANJAY GANDHI POSTGRAD INST MED SCI, DEPT MED GENET, LUCKNOW, UTTAR PRADESH, INDIA
关键词
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Human leukocyte antigens (HLAs) are an inherent system of alloantigens, which are the products of genes of the major histocompatibility complex (MHC). These genes span a region of approximately 4 centimorgans on the short arm of human chromosome 6 at band p 21.3 and encode the HLA class I and class II antigens, which play a central role in cell-to-cell interaction in the immune system. These antigens interact with the antigen-specific cell surface receptors of T lymphocytes (TCR) thus causing activation of the lymphocytes and the resulting immune response. Class antigens restrict cytotoxic T-cell (CD8+) function thus killing viral infected targets, while class II antigens are involved in presentation of exogenous antigens to T-helper cells (CD4+) by antigen presenting cells (APC). The APC processes the antigens, and the immunogenic peptide is then presented at the cell surface along with the MHC molecule for recognition by the TCR. Since the MHC molecules play a central role in regulating the immune response, they may have an important role in controlling resistance and susceptibility to diseases. In this review we have highlighted studies conducted to look for an association between HLA and infectious diseases; such studies have had a variable degree of success because the pathogenesis of different diseases varies widely, and most diseases have a polygenic etiology.
引用
收藏
页码:41 / 49
页数:9
相关论文
共 50 条
  • [21] Epidemiology of emerging infectious diseases in Singapore, with special reference to SARS
    Goh, Kee Tai
    Chew, Suok Kai
    POPULATION DYNAMICS AND INFECTIOUS DISEASES IN ASIA, 2006, : 287 - 303
  • [22] Elevation of soluble major histocompatibility complex class I related chain A protein in malignant and infectious diseases in Chinese patients
    Jiang, Xiaoxin
    Huang, Ju-Fang
    Huo, Zhi
    Zhang, Qiuqui
    Jiang, Yan
    Wu, Xiaoping
    Li, Yanwen
    Jiang, Guanmin
    Zeng, Leping
    Yan, Xiao-Xin
    Yu, Ping
    Cao, Renxian
    BMC IMMUNOLOGY, 2012, 13
  • [23] An address on immunity against infectious disease, with special reference to antityphoid inoculation
    McWeeney, EJ
    LANCET, 1915, 1 : 265 - 269
  • [24] THE MAJOR HISTOCOMPATIBILITY COMPLEX
    VASEY, FB
    ESPINOZA, LR
    BOCANEGRA, TS
    GERMAIN, BF
    ANNALS OF CLINICAL AND LABORATORY SCIENCE, 1982, 12 (01): : 16 - 22
  • [25] THE MAJOR HISTOCOMPATIBILITY COMPLEX
    LEVY, D
    BIOFUTUR, 1988, (69) : 47 - 51
  • [26] Immunity in Infectious Diseases
    Larkum, N. W.
    AMERICAN JOURNAL OF PUBLIC HEALTH AND THE NATIONS HEALTH, 1930, 20 (09): : 1042 - 1042
  • [27] HISTOCOMPATIBILITY ANTIGENS AND INFECTIOUS-DISEASES
    PETRUNIN, YP
    BOKOVOI, AG
    TULCHENETSKAYA, AT
    NELYUBIN, OV
    ZHURNAL MIKROBIOLOGII EPIDEMIOLOGII I IMMUNOBIOLOGII, 1982, (04): : 15 - 22
  • [28] Major histocompatibility complex (MHC) molecules: their common characteristics and relations with diseases
    Yalcin, Basak
    TURKDERM-TURKISH ARCHIVES OF DERMATOLOGY AND VENEROLOGY, 2013, 47 : 12 - 17
  • [29] THE MAJOR HISTOCOMPATIBILITY COMPLEX - PROSPECTS FOR RATIONAL THERAPY OF AUTOIMMUNE-DISEASES
    NEPOM, GT
    CLINICAL IMMUNOTHERAPEUTICS, 1994, 2 (02): : 79 - 83
  • [30] Major histocompatibility complex diversity influences parasite resistance and innate immunity in sticklebacks
    Kurtz, J
    Kalbe, M
    Aeschlimann, PB
    Häberli, MA
    Wegner, KM
    Reusch, TBH
    Milinski, M
    PROCEEDINGS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES, 2004, 271 (1535) : 197 - 204